Evidence map›Paper›PMID 39777987›Full record

ArticleThe FEBS journal2025

Identification of an exosite at the neutrophil elastase/alpha-1-antitrypsin interface.

Roberto Gangemi, Mattia Bignotti, Andrea Denardo, Claudia N Pearce, Riccardo Ronzoni, David A Lomas, James A Irving, Annamaria Fra, Fabrizio Gangemi

Abstract read
In one paragraph

Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Roberto GangemiPhysics, Department of Molecular and Translational Medicine, University of Brescia, Italy.
Mattia BignottiExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, Italy.ORCID 0000-0002-8598-4832
Andrea DenardoExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, Italy.ORCID 0000-0001-7844-0928
Claudia N PearceUCL Respiratory and the Institute of Structural and Molecular Biology, University College London, UK.ORCID 0009-0003-2726-0179
Riccardo RonzoniUCL Respiratory and the Institute of Structural and Molecular Biology, University College London, UK.ORCID 0000-0002-3981-8104
David A LomasUCL Respiratory and the Institute of Structural and Molecular Biology, University College London, UK.ORCID 0000-0003-2339-6979
James A IrvingUCL Respiratory and the Institute of Structural and Molecular Biology, University College London, UK.ORCID 0000-0003-3204-6356
Annamaria FraExperimental Oncology and Immunology, Department of Molecular and Translational Medicine, University of Brescia, Italy.ORCID 0000-0002-4327-3004
Fabrizio GangemiPhysics, Department of Molecular and Translational Medicine, University of Brescia, Italy.ORCID 0000-0001-9389-651X

Funding

Alpha-1 Foundation 829920Medical Research Council MR/V034243/1University College London Hospitals Biomedical Research Centre
6 · The paper itself

Abstract

Neutrophil elastase (NE) is released by activated neutrophils during an inflammatory response and exerts proteolytic activity on elastin and other extracellular matrix components. This protease is rapidly inhibited by the plasma serine protease inhibitor alpha-1-antitrypsin (AAT), and the importance of this protective activity on lung tissue is highlighted by the development of early onset emphysema in individuals with AAT deficiency. As a serpin, AAT presents a surface-exposed reactive centre loop (RCL) whose sequence mirrors the target protease specificity. Following binding of NE in a 'Michaelis' encounter complex, cleavage of the RCL results in an irreversible complex between the two molecules. Here, the structure of the AAT-NE encounter complex was studied by molecular dynamics, mutagenesis and enzyme kinetics. Exploration of the geometry of interaction between the two molecules revealed the possibility that the interaction interface extends beyond the RCL; a persistent feature of the simulations was the interaction between a region located upstream of β-strand 4C of AAT, comprising three acidic residues (Asp202, Glu199 and Glu204), and Arg147 of NE. Mutation of the acidic residues to either alanine or serine, or a D202R substitution, resulted in a reduced rate of association between recombinant AAT and NE. Addition of salt to the buffer had little effect for these mutants but substantially reduced the rate of interaction of the wild-type protein. These data are consistent with a role for this acidic region on AAT as an exosite that contributes to an optimal interaction with its physiological protease target.

Indexed as

alpha 1-AntitrypsinLeukocyte ElastaseBinding SitesHumansKineticsMolecular Dynamics SimulationMutationProtein Bindingalpha 1-AntitrypsinELANE protein, humanLeukocyte ElastaseSERPINA1 protein, humanalpha‐1‐antitrypsin deficiencycomputational biologymolecular dynamics simulationsprotease inhibitionprotein–protein interactionsSERPINA1Serpins

Identifiers

PMID39777987
PMCPMC12001179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.